Total trials
328
Active
63
Phase 3
28
Total enrollment
138,946
Pipeline matrix
Showing 20 of 20 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| OnabotulinumtoxinA 100 UNT | — | — | — | — | — | 1 | |
| Phenazopyridine Hydrochloride 99.5 MG | — | — | — | — | — | 1 | |
| Patients will receive topical Acoltremon 0.003% ophthalmic solution BID in both eyes over an 8 week period. | — | — | — | — | — | 1 | |
| Oxymetazoline Hydrochloride | — | — | — | — | 2 | ||
| Exparel | — | — | — | — | — | 1 | |
| 5 mg prednisone | — | — | — | — | — | 1 | |
| 0 mg prednisone | — | — | — | — | — | 1 | |
| Oxygen 99.7 % | — | — | — | — | — | 1 | |
| Oxygen 21 % | — | — | — | — | — | 1 | |
| Neuromuscular Blocking Agents | — | — | — | — | — | 1 | |
| Ropivacaine | — | — | — | — | 2 | ||
| Efgartigimod | — | — | — | — | — | 1 | |
| Chloroquine Phosphate | — | — | — | — | — | 1 | |
| Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT] | — | — | — | — | — | 1 | |
| Rimegepant | — | — | — | — | — | 1 | |
| Zavegepant | — | — | — | — | — | 1 | |
| Montelukast 10 Mg Oral | — | — | — | — | — | 1 | |
| Montelukast 10 Mg Oral Tablet and SPM 4 g | — | — | — | — | — | 1 | |
| Lactated Ringer | — | — | — | — | — | 1 | |
| Normal Saline 0.9% Infusion Solution Bag | — | — | — | — | — | 1 |
Next readouts
- 2018-08-01
- 2020-03
- 2020-03-01
- 2020-03-01
- 2021-01-01
- 2025-07
- 2025-11-24
- 2025-12-31
- 2026-03
- 2026-04
Top conditions
- Depression10
- Generalized Anxiety Disorder9
- Obsessive-compulsive Disorder9
- Breast Cancer7
- Social Phobia7
- Separation Anxiety Disorder7
- Multiple Sclerosis6
- Anxiety6
Frequently asked questions about University of South Florida
- How many clinical trials does University of South Florida have on ClinicalTrials.gov?
- University of South Florida is listed as the lead sponsor on 328 clinical trials in ClinicalTrials.gov, 63 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of South Florida's trials are in Phase 3?
- 28 of University of South Florida's trials are in Phase 3, spread across 20 active drug programs.
- What therapeutic areas does University of South Florida focus on?
- University of South Florida's most-studied conditions on ClinicalTrials.gov are Depression, Generalized Anxiety Disorder, Obsessive-compulsive Disorder, Breast Cancer, Social Phobia.
- When are University of South Florida's next clinical trial readouts?
- University of South Florida has 10 upcoming primary-completion readouts tracked here; the soonest is “Lactated Ringer's Solution to Prevent Post-ERCP Pancreatitis”, expected around 2018-08-01.